|
⚲
|
| Keyboard |
| Mark Litton | |
|---|---|
| Firm | |
| Address | c/o Lumen Bioscience, Inc 1441 North 34th Street, Suite 300 Seattle, WA 98103 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Lumen Bioscience Inc | 021-542649 | Director | of 23.0 M |
||
| Lumen Bioscience Inc | 021-529787 | Director | of 18.3 M |
||
| Lumen Bioscience Inc | 021-492191 | Director | of 33.0 M |
||
| Lumen Bioscience Inc | 021-450591 | Director | of 50.5 M |
||
| Athira Pharma Inc | 021-368812 | Executive Officer | 89.0 M of 90.9 M |
||
| Alpine Immune Sciences Inc | 021-331755 | Executive Officer | 25.3 M of 48.7 M |
||
| Athira Pharma Inc | 021-328537 | Executive Officer | 3.8 M of 4.7 M |
||
| Alder Biopharmaceuticals Inc | 021-304199 | Executive Officer | 100.0 M of 260.3 M |
||